Delayed
Japan Exchange
01:20:04 2024-05-29 am EDT
|
5-day change
|
1st Jan Change
|
2,168
JPY
|
-2.08%
|
|
-6.08%
|
-13.14%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
378,636
|
403,395
|
506,714
|
612,670
|
977,203
|
922,630
|
-
|
-
|
Enterprise Value (EV)
1 |
341,076
|
399,207
|
491,897
|
561,071
|
903,391
|
1,017,592
|
798,780
|
765,328
|
P/E ratio
|
15.4
x
|
15.4
x
|
23.5
x
|
15.3
x
|
24.3
x
|
19.5
x
|
16.8
x
|
15.7
x
|
Yield
|
1.76%
|
1.78%
|
1.42%
|
1.61%
|
1.21%
|
1.5%
|
1.88%
|
1.88%
|
Capitalization / Revenue
|
0.66
x
|
0.68
x
|
0.91
x
|
0.84
x
|
1.03
x
|
1
x
|
0.86
x
|
0.83
x
|
EV / Revenue
|
0.59
x
|
0.68
x
|
0.88
x
|
0.77
x
|
0.95
x
|
1
x
|
0.75
x
|
0.69
x
|
EV / EBITDA
|
7.71
x
|
8.68
x
|
12.3
x
|
10.7
x
|
10.9
x
|
8.6
x
|
7.69
x
|
7.05
x
|
EV / FCF
|
28.8
x
|
25.2
x
|
22.1
x
|
23.1
x
|
20.4
x
|
28.7
x
|
15.4
x
|
13.6
x
|
FCF Yield
|
3.47%
|
3.96%
|
4.52%
|
4.34%
|
4.91%
|
3.48%
|
6.49%
|
7.35%
|
Price to Book
|
1.81
x
|
1.76
x
|
2.05
x
|
1.32
x
|
2.03
x
|
1.98
x
|
1.66
x
|
1.55
x
|
Nbr of stocks (in thousands)
|
308,252
|
307,935
|
308,345
|
423,993
|
418,204
|
416,725
|
-
|
-
|
Reference price
2 |
1,228
|
1,310
|
1,643
|
1,445
|
2,337
|
2,214
|
2,214
|
2,214
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
575,991
|
590,593
|
556,907
|
729,969
|
951,247
|
1,022,531
|
1,067,769
|
1,108,432
|
EBITDA
1 |
44,261
|
45,966
|
40,111
|
52,459
|
83,116
|
96,214
|
103,902
|
108,627
|
EBIT
1 |
36,028
|
37,563
|
31,533
|
41,407
|
62,276
|
75,705
|
82,182
|
88,120
|
Operating Margin
|
6.25%
|
6.36%
|
5.66%
|
5.67%
|
6.55%
|
7.4%
|
7.7%
|
7.95%
|
Earnings before Tax (EBT)
1 |
37,369
|
39,078
|
32,617
|
49,629
|
64,908
|
81,246
|
85,335
|
91,389
|
Net income
1 |
25,035
|
26,176
|
21,568
|
34,588
|
40,545
|
52,347
|
54,993
|
59,071
|
Net margin
|
4.35%
|
4.43%
|
3.87%
|
4.74%
|
4.26%
|
5.12%
|
5.15%
|
5.33%
|
EPS
2 |
79.81
|
85.01
|
70.04
|
94.38
|
96.02
|
125.3
|
131.5
|
141.3
|
Free Cash Flow
1 |
11,846
|
15,820
|
22,245
|
24,327
|
44,392
|
35,463
|
51,844
|
56,258
|
FCF margin
|
2.06%
|
2.68%
|
3.99%
|
3.33%
|
4.67%
|
3.47%
|
4.86%
|
5.08%
|
FCF Conversion (EBITDA)
|
26.76%
|
34.42%
|
55.46%
|
46.37%
|
53.41%
|
44.88%
|
49.9%
|
51.79%
|
FCF Conversion (Net income)
|
47.32%
|
60.44%
|
103.14%
|
70.33%
|
109.49%
|
67.75%
|
94.28%
|
95.24%
|
Dividend per Share
2 |
21.67
|
23.33
|
23.33
|
23.33
|
28.33
|
36.67
|
41.60
|
41.72
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
300,415
|
273,846
|
139,517
|
277,003
|
230,854
|
222,112
|
227,209
|
237,866
|
465,075
|
249,201
|
236,971
|
248,222
|
259,544
|
507,766
|
262,567
|
252,198
|
257,849
|
268,622
|
274,925
|
265,079
|
EBITDA
|
-
|
-
|
10,640
|
-
|
17,063
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
18,424
|
14,496
|
8,429
|
15,785
|
12,010
|
13,612
|
12,360
|
15,962
|
28,322
|
20,036
|
13,918
|
17,450
|
20,104
|
37,554
|
21,194
|
16,957
|
18,707
|
21,140
|
22,940
|
19,046
|
Operating Margin
|
6.13%
|
5.29%
|
6.04%
|
5.7%
|
5.2%
|
6.13%
|
5.44%
|
6.71%
|
6.09%
|
8.04%
|
5.87%
|
7.03%
|
7.75%
|
7.4%
|
8.07%
|
6.72%
|
7.25%
|
7.87%
|
8.34%
|
7.19%
|
Earnings before Tax (EBT)
|
19,305
|
14,665
|
-
|
15,905
|
23,526
|
-
|
13,360
|
-
|
30,153
|
21,298
|
-
|
18,451
|
-
|
40,323
|
24,892
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
12,952
|
9,729
|
5,088
|
10,305
|
18,458
|
5,825
|
7,930
|
10,574
|
18,504
|
13,755
|
8,286
|
11,997
|
13,841
|
25,838
|
16,456
|
10,053
|
12,825
|
14,070
|
15,624
|
12,231
|
Net margin
|
4.31%
|
3.55%
|
3.65%
|
3.72%
|
8%
|
2.62%
|
3.49%
|
4.45%
|
3.98%
|
5.52%
|
3.5%
|
4.83%
|
5.33%
|
5.09%
|
6.27%
|
3.99%
|
4.97%
|
5.24%
|
5.68%
|
4.61%
|
EPS
2 |
42.07
|
31.60
|
16.65
|
33.66
|
49.24
|
-
|
18.70
|
-
|
43.69
|
32.57
|
-
|
28.69
|
33.10
|
61.79
|
39.41
|
24.11
|
30.64
|
33.23
|
36.85
|
27.87
|
Dividend per Share
2 |
11.67
|
11.67
|
-
|
11.67
|
-
|
-
|
-
|
-
|
13.33
|
-
|
-
|
-
|
16.67
|
16.67
|
-
|
20.00
|
-
|
21.00
|
-
|
21.00
|
Announcement Date
|
11/13/19
|
11/13/20
|
11/15/21
|
11/15/21
|
2/14/22
|
5/13/22
|
8/12/22
|
11/14/22
|
11/14/22
|
2/14/23
|
5/12/23
|
8/10/23
|
11/14/23
|
11/14/23
|
2/14/24
|
5/10/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
37,560
|
4,188
|
14,817
|
51,599
|
73,812
|
95,438
|
123,850
|
157,303
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
11,846
|
15,820
|
22,245
|
24,327
|
44,392
|
35,463
|
51,844
|
56,258
|
ROE (net income / shareholders' equity)
|
12.1%
|
11.9%
|
9.07%
|
9.7%
|
8.6%
|
10.5%
|
10.3%
|
10.3%
|
ROA (Net income/ Total Assets)
|
12.3%
|
11.9%
|
9.46%
|
8.75%
|
9.92%
|
11.4%
|
9.59%
|
9.78%
|
Assets
1 |
203,439
|
219,350
|
227,989
|
395,217
|
408,624
|
459,384
|
573,705
|
603,778
|
Book Value Per Share
2 |
680.0
|
745.0
|
800.0
|
1,095
|
1,154
|
1,234
|
1,331
|
1,427
|
Cash Flow per Share
2 |
103.0
|
109.0
|
84.00
|
125.0
|
130.0
|
163.0
|
181.0
|
193.0
|
Capex
1 |
10,051
|
8,944
|
3,630
|
11,916
|
19,853
|
28,043
|
23,385
|
23,763
|
Capex / Sales
|
1.74%
|
1.51%
|
0.65%
|
1.63%
|
2.09%
|
2.74%
|
2.19%
|
2.14%
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/13/21
|
5/13/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Last Close Price
2,214
JPY Average target price
2,945
JPY Spread / Average Target +33.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.38% | 5.97B | | -41.10% | 13.83B | | -27.88% | 11.5B | | +14.31% | 6.41B | | -19.10% | 6.32B | | +72.00% | 5B | | -3.36% | 4.63B | | -6.07% | 3.96B | | -18.47% | 3.24B | | -12.53% | 2.85B |
Other Drug Retailers
|